Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232
GSK2838232 (GSK232) is a novel maturation inhibitor that blocks the proteolytic cleavage of HIV-1 Gag at the junction of capsid and spacer peptide 1 (CA/SP1), rendering newly-formed virions non-infectious. To our knowledge, GSK232 has not been tested against HIV-2, and there are limited data regardi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847912/?tool=EBI |
Search Result 1
Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232.
Published 2023-01-01
Get full text
Article